Literature DB >> 32445515

Rapid volumetric gagCEST imaging of knee articular cartilage at 3 T: evaluation of improved dynamic range and an osteoarthritic population.

Lauren E Watkins1, Elka B Rubin2, Valentina Mazzoli2, Scott D Uhlrich3, Arjun D Desai4, Marianne Black2,3, Gabe K Ho1, Scott L Delp1,3,5, Marc E Levenston1,3, Gary S Beaupré1,6, Garry E Gold1,2,5, Feliks Kogan2.   

Abstract

Chemical exchange saturation transfer of glycosaminoglycans, gagCEST, is a quantitative MR technique that has potential for assessing cartilage proteoglycan content at field strengths of 7 T and higher. However, its utility at 3 T remains unclear. The objective of this work was to implement a rapid volumetric gagCEST sequence with higher gagCEST asymmetry at 3 T to evaluate its sensitivity to osteoarthritic changes in knee articular cartilage and in comparison with T2 and T1ρ measures. We hypothesize that gagCEST asymmetry at 3 T decreases with increasing severity of osteoarthritis (OA). Forty-two human volunteers, including 10 healthy subjects and 32 subjects with medial OA, were included in the study. Knee Injury and Osteoarthritis Outcome Scores (KOOS) were assessed for all subjects, and Kellgren-Lawrence grading was performed for OA volunteers. Healthy subjects were scanned consecutively at 3 T to assess the repeatability of the volumetric gagCEST sequence at 3 T. For healthy and OA subjects, gagCEST asymmetry and T2 and T1ρ relaxation times were calculated for the femoral articular cartilage to assess sensitivity to OA severity. Volumetric gagCEST imaging had higher gagCEST asymmetry than single-slice acquisitions (p = 0.015). The average scan-rescan coefficient of variation was 6.8%. There were no significant differences in average gagCEST asymmetry between younger and older healthy controls (p = 0.655) or between healthy controls and OA subjects (p = 0.310). T2 and T1ρ relaxation times were elevated in OA subjects (p < 0.001 for both) compared with healthy controls and both were moderately correlated with total KOOS scores (rho = -0.181 and rho = -0.332 respectively). The gagCEST technique developed here, with volumetric scan times under 10 min and high gagCEST asymmetry at 3 T, did not vary significantly between healthy subjects and those with mild-moderate OA. This further supports a limited utility for gagCEST imaging at 3 T for assessment of early changes in cartilage composition in OA.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  CEST; cartilage; gagCEST; human study; knee; osteoarthritis

Year:  2020        PMID: 32445515      PMCID: PMC7347437          DOI: 10.1002/nbm.4310

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  26 in total

1.  Artifacts in T(1rho)-weighted imaging: correction with a self-compensating spin-locking pulse.

Authors:  Sridhar R Charagundla; Arijitt Borthakur; John S Leigh; Ravinder Reddy
Journal:  J Magn Reson       Date:  2003-05       Impact factor: 2.229

2.  elastix: a toolbox for intensity-based medical image registration.

Authors:  Stefan Klein; Marius Staring; Keelin Murphy; Max A Viergever; Josien P W Pluim
Journal:  IEEE Trans Med Imaging       Date:  2009-11-17       Impact factor: 10.048

3.  High quality three-dimensional gagCEST imaging of in vivo human knee cartilage at 7 Tesla.

Authors:  Guruprasad Krishnamoorthy; Ravi Prakash Reddy Nanga; Puneet Bagga; Hari Hariharan; Ravinder Reddy
Journal:  Magn Reson Med       Date:  2016-05-13       Impact factor: 4.668

4.  Quantitative MRI using T1ρ and T2 in human osteoarthritic cartilage specimens: correlation with biochemical measurements and histology.

Authors:  Xiaojuan Li; Jonathan Cheng; Katrina Lin; Ehsan Saadat; Radu I Bolbos; Björn Jobke; Michael D Ries; Andrew Horvai; Thomas M Link; Sharmila Majumdar
Journal:  Magn Reson Imaging       Date:  2010-12-03       Impact factor: 2.546

5.  Reproducibility and regional variations of an improved gagCEST protocol for the in vivo evaluation of knee cartilage at 7 T.

Authors:  Markus M Schreiner; Štefan Zbýň; Benjamin Schmitt; Michael Weber; Stephan Domayer; Reinhard Windhager; Siegfried Trattnig; Vladimir Mlynárik
Journal:  MAGMA       Date:  2016-03-10       Impact factor: 2.310

6.  Cluster analysis of quantitative MRI T2 and T relaxation times of cartilage identifies differences between healthy and ACL-injured individuals at 3T.

Authors:  U D Monu; C D Jordan; B L Samuelson; B A Hargreaves; G E Gold; E J McWalter
Journal:  Osteoarthritis Cartilage       Date:  2016-10-05       Impact factor: 6.576

7.  Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST).

Authors:  Wen Ling; Ravinder R Regatte; Gil Navon; Alexej Jerschow
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

8.  Cartilage quality assessment by using glycosaminoglycan chemical exchange saturation transfer and (23)Na MR imaging at 7 T.

Authors:  Benjamin Schmitt; Stefan Zbýn; David Stelzeneder; Vladimir Jellus; Dominik Paul; Lars Lauer; Peter Bachert; Siegfried Trattnig
Journal:  Radiology       Date:  2011-04-01       Impact factor: 11.105

Review 9.  Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis.

Authors:  L J Sandell; T Aigner
Journal:  Arthritis Res       Date:  2001-01-22

10.  Detection of early cartilage damage: feasibility and potential of gagCEST imaging at 7T.

Authors:  Sander Brinkhof; Razmara Nizak; Vitaliy Khlebnikov; Jeanine J Prompers; Dennis W J Klomp; Daniel B F Saris
Journal:  Eur Radiol       Date:  2018-01-30       Impact factor: 5.315

View more
  1 in total

1.  Patellar instability MRI measurements are associated with knee joint degeneration after reconstruction of the medial patellofemoral ligament.

Authors:  Paula Giesler; Frederic A Baumann; Dominik Weidlich; Dimitrios C Karampinos; Matthias Jung; Christian Holwein; Julia Schneider; Alexandra S Gersing; Andreas B Imhoff; Fabian Bamberg; Pia M Jungmann
Journal:  Skeletal Radiol       Date:  2021-07-04       Impact factor: 2.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.